Persistence, Immune Specificity, and Functional Ability of Murine Mutant Ras Epitope-Specific CD4+ and CD8+ T Lymphocytes Following in Vivo Adoptive Transfer

This publication has 16 references indexed in Scilit:

• Identification of a Human CD8+T Lymphocyte Neo-epitope Created by arasCodon 12 Mutation Which Is Restricted by the HLA-A2 Allele
  Cellular Immunology, 1998
• Generation of Stable CD4+and CD8+T Cell Lines from Patients Immunized withrasOncogene-Derived Peptides Reflecting Codon 12 Mutations
  Cellular Immunology, 1997
• Treatment of Subcutaneous Tumor with Adoptively Transferred T Cells
  Cellular Immunology, 1997
• Adoptive Immunotherapy as an In Vivo Model to Explore Antitumor Mechanisms Induced by a Recombinant Anticancer Vaccine
  Journal of Immunotherapy, 1997
• Comparison of Linear and Branched Peptide Forms (MAPs) in the Induction of T Helper Responses to Point-Mutated ras Immunogens
  Cellular Immunology, 1996
• Peptide‐specific activation of cytolytic CD4⁺ T lymphocytes against tumor cells bearing mutated epitopes of K‐ras p21
  European Journal of Immunology, 1995
• Activation of T lymphocytes for the adoptive immunotherapy of cancer
  Annals of Surgical Oncology, 1994
• T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire.
  The Journal of Experimental Medicine, 1991
• Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells
  Published by Elsevier ,1991
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988